Botulinum toxin treatment of occupational and focal hand dystonia
Identifieur interne : 003D94 ( Main/Curation ); précédent : 003D93; suivant : 003D95Botulinum toxin treatment of occupational and focal hand dystonia
Auteurs : Barbara Illowsky Karp [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2004-03.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Anti-Dyskinesia Agents (therapeutic use), Bontoxilysin, Botulinum Toxins (therapeutic use), Botulinum toxin writer's cramp dystonias injection focal hand dystonia, Dystonia, Dystonic Disorders (drug therapy), Electromyography, Humans, Nervous system diseases, Occupational Diseases (drug therapy), Treatment, Treatment Outcome.
- MESH :
- chemical , therapeutic use : Anti-Dyskinesia Agents, Botulinum Toxins.
- drug therapy : Dystonic Disorders, Occupational Diseases.
- Electromyography, Humans, Treatment Outcome.
Abstract
Botulinum toxin is now the first‐line therapy for writer's cramp and other occupational dystonias, with well‐established efficacy and safety. Future studies will allow us to understand better the physiological effects of injection and to refine and enhance our treatment of focal hand dystonia. © 2004 Movement Disorder Society
Url:
DOI: 10.1002/mds.20025
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003679
- to stream Istex, to step Curation: Pour aller vers cette notice dans l'étape Curation :003679
- to stream Istex, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002775
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003504
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :003504
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :003542
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000D80
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :000D80
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000D80
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :005752
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002249
- to stream PascalFrancis, to step Curation: Pour aller vers cette notice dans l'étape Curation :000A72
- to stream PascalFrancis, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002226
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :005A64
Links to Exploration step
ISTEX:6C92BE8819E51B8CAC53DDD05479235DBAB6507BLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Botulinum toxin treatment of occupational and focal hand dystonia</title>
<author><name sortKey="Karp, Barbara Illowsky" sort="Karp, Barbara Illowsky" uniqKey="Karp B" first="Barbara Illowsky" last="Karp">Barbara Illowsky Karp</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6C92BE8819E51B8CAC53DDD05479235DBAB6507B</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1002/mds.20025</idno>
<idno type="url">https://api.istex.fr/document/6C92BE8819E51B8CAC53DDD05479235DBAB6507B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003679</idno>
<idno type="wicri:Area/Istex/Curation">003679</idno>
<idno type="wicri:Area/Istex/Checkpoint">002775</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Karp B:botulinum:toxin:treatment</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15027063</idno>
<idno type="wicri:Area/PubMed/Corpus">003504</idno>
<idno type="wicri:Area/PubMed/Curation">003504</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003542</idno>
<idno type="wicri:Area/Ncbi/Merge">000D80</idno>
<idno type="wicri:Area/Ncbi/Curation">000D80</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000D80</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Karp B:botulinum:toxin:treatment</idno>
<idno type="wicri:Area/Main/Merge">005752</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:04-0228273</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002249</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000A72</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002226</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Karp B:botulinum:toxin:treatment</idno>
<idno type="wicri:Area/Main/Merge">005A64</idno>
<idno type="wicri:Area/Main/Curation">003D94</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Botulinum toxin treatment of occupational and focal hand dystonia</title>
<author><name sortKey="Karp, Barbara Illowsky" sort="Karp, Barbara Illowsky" uniqKey="Karp B" first="Barbara Illowsky" last="Karp">Barbara Illowsky Karp</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2004-03">2004-03</date>
<biblScope unit="vol">19</biblScope>
<biblScope unit="issue">S8</biblScope>
<biblScope unit="page" from="S116">S116</biblScope>
<biblScope unit="page" to="S119">S119</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">6C92BE8819E51B8CAC53DDD05479235DBAB6507B</idno>
<idno type="DOI">10.1002/mds.20025</idno>
<idno type="ArticleID">MDS20025</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Dyskinesia Agents (therapeutic use)</term>
<term>Bontoxilysin</term>
<term>Botulinum Toxins (therapeutic use)</term>
<term>Botulinum toxin writer's cramp dystonias injection focal hand dystonia</term>
<term>Dystonia</term>
<term>Dystonic Disorders (drug therapy)</term>
<term>Electromyography</term>
<term>Humans</term>
<term>Nervous system diseases</term>
<term>Occupational Diseases (drug therapy)</term>
<term>Treatment</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Dyskinesia Agents</term>
<term>Botulinum Toxins</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dystonic Disorders</term>
<term>Occupational Diseases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Electromyography</term>
<term>Humans</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Bontoxilysin</term>
<term>Dystonie</term>
<term>Système nerveux pathologie</term>
<term>Traitement</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Botulinum toxin is now the first‐line therapy for writer's cramp and other occupational dystonias, with well‐established efficacy and safety. Future studies will allow us to understand better the physiological effects of injection and to refine and enhance our treatment of focal hand dystonia. © 2004 Movement Disorder Society</div>
</front>
</TEI>
<double idat="0885-3185:2004:Karp B:botulinum:toxin:treatment"><INIST><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Botulinum toxin treatment of occupational and focal hand dystonia</title>
<author><name sortKey="Karp, Barbara Illowsky" sort="Karp, Barbara Illowsky" uniqKey="Karp B" first="Barbara Illowsky" last="Karp">Barbara Illowsky Karp</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">04-0228273</idno>
<date when="2004">2004</date>
<idno type="stanalyst">PASCAL 04-0228273 INIST</idno>
<idno type="RBID">Pascal:04-0228273</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002249</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000A72</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002226</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Karp B:botulinum:toxin:treatment</idno>
<idno type="wicri:Area/Main/Merge">005A64</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Botulinum toxin treatment of occupational and focal hand dystonia</title>
<author><name sortKey="Karp, Barbara Illowsky" sort="Karp, Barbara Illowsky" uniqKey="Karp B" first="Barbara Illowsky" last="Karp">Barbara Illowsky Karp</name>
<affiliation wicri:level="2"><inist:fA14 i1="01"><s1>National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda, Maryland</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2004">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Bontoxilysin</term>
<term>Dystonia</term>
<term>Nervous system diseases</term>
<term>Treatment</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Dystonie</term>
<term>Bontoxilysin</term>
<term>Traitement</term>
<term>Système nerveux pathologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Botulinum toxin is now the first-line therapy for writer's cramp and other occupational dystonias, with well-established efficacy and safety. Future studies will allow us to understand better the physiological effects of injection and to refine and enhance our treatment of focal hand dystonia.</div>
</front>
</TEI>
</INIST>
<ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Botulinum toxin treatment of occupational and focal hand dystonia</title>
<author><name sortKey="Karp, Barbara Illowsky" sort="Karp, Barbara Illowsky" uniqKey="Karp B" first="Barbara Illowsky" last="Karp">Barbara Illowsky Karp</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:6C92BE8819E51B8CAC53DDD05479235DBAB6507B</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1002/mds.20025</idno>
<idno type="url">https://api.istex.fr/document/6C92BE8819E51B8CAC53DDD05479235DBAB6507B/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003679</idno>
<idno type="wicri:Area/Istex/Curation">003679</idno>
<idno type="wicri:Area/Istex/Checkpoint">002775</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Karp B:botulinum:toxin:treatment</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15027063</idno>
<idno type="wicri:Area/PubMed/Corpus">003504</idno>
<idno type="wicri:Area/PubMed/Curation">003504</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003542</idno>
<idno type="wicri:Area/Ncbi/Merge">000D80</idno>
<idno type="wicri:Area/Ncbi/Curation">000D80</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000D80</idno>
<idno type="wicri:doubleKey">0885-3185:2004:Karp B:botulinum:toxin:treatment</idno>
<idno type="wicri:Area/Main/Merge">005752</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Botulinum toxin treatment of occupational and focal hand dystonia</title>
<author><name sortKey="Karp, Barbara Illowsky" sort="Karp, Barbara Illowsky" uniqKey="Karp B" first="Barbara Illowsky" last="Karp">Barbara Illowsky Karp</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2004-03">2004-03</date>
<biblScope unit="vol">19</biblScope>
<biblScope unit="issue">S8</biblScope>
<biblScope unit="page" from="S116">S116</biblScope>
<biblScope unit="page" to="S119">S119</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">6C92BE8819E51B8CAC53DDD05479235DBAB6507B</idno>
<idno type="DOI">10.1002/mds.20025</idno>
<idno type="ArticleID">MDS20025</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Dyskinesia Agents (therapeutic use)</term>
<term>Botulinum Toxins (therapeutic use)</term>
<term>Botulinum toxin writer's cramp dystonias injection focal hand dystonia</term>
<term>Dystonic Disorders (drug therapy)</term>
<term>Electromyography</term>
<term>Humans</term>
<term>Occupational Diseases (drug therapy)</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Dyskinesia Agents</term>
<term>Botulinum Toxins</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Dystonic Disorders</term>
<term>Occupational Diseases</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Electromyography</term>
<term>Humans</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Botulinum toxin is now the first‐line therapy for writer's cramp and other occupational dystonias, with well‐established efficacy and safety. Future studies will allow us to understand better the physiological effects of injection and to refine and enhance our treatment of focal hand dystonia. © 2004 Movement Disorder Society</div>
</front>
</TEI>
</ISTEX>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D94 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 003D94 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Curation |type= RBID |clé= ISTEX:6C92BE8819E51B8CAC53DDD05479235DBAB6507B |texte= Botulinum toxin treatment of occupational and focal hand dystonia }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |